Education
About Us
Working with TipRanks
Follow Us
U.s. Physical Therapy (USPH)
NYSE:USPH
USPH Stock Chart & Stats
$82.12
$0.25(0.28%)
At close: 4:00 PM EST
$82.12
$0.25(0.28%)
Day’s Range― - ―
52-Week Range$62.77 - $93.50
Previous CloseN/A
Volume11.83K
Average Volume (3M)188.06K
Market Cap
$1.26B
Enterprise Value$1.56B
Total Cash (Recent Filing)$31.10M
Total Debt (Recent Filing)$308.40M
Price to Earnings (P/E)34.7
Beta1.15
Next Earnings
Mar 04, 2026EPS Estimate
0.67Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.66
Shares Outstanding15,204,119
10 Day Avg. Volume195,577
30 Day Avg. Volume188,055
Financial Highlights & Ratios
PEG Ratio1.15
Price to Book (P/B)2.73
Price to Sales (P/S)1.99
P/FCF Ratio20.32
Enterprise Value/Market Cap1.24
Enterprise Value/Revenue2.35
Enterprise Value/Gross Profit10.86
Enterprise Value/Ebitda13.67
Forecast
1Y Price Target
$103.00Price Target Upside25.43% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Payer Mix ImprovementPruning lower-margin Medicare Advantage contracts in favor of higher-margin commercial and workers' compensation payers can bolster profit margins per visit.
Reimbursement OutlookManagement's anticipation of a more stable Medicare reimbursement environment could ease rate pressure and increase available staff capacity to support clinic operations.
Revenue DiversificationExpansion into home-based care, cash-pay services, on-site employer clinics and the industrial injury prevention business can diversify revenue sources and reduce reliance on traditional clinic volumes.
Bears Say
Home-care ScalabilityConcentration of home-care services in high-cost regions may limit expansion into lower-rate markets, constraining growth potential for that segment.
Rate Pressure Per VisitNet rate per visit slightly underperformed internal estimates and a decline in Medicare rates points to ongoing pricing pressure that could weigh on revenue per treatment.
Volume Exposure From Payer PruningTrimming Medicare Advantage contracts to improve margins could reduce patient volumes and increase dependence on commercial payers for sustained growth.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $62.77 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.26B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Mar 04, 2026 which is in 26 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on Nov 05, 2025. The company reported $0.66 earnings per share for the quarter, missing the consensus estimate of $0.67 by -$0.01.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.45 which represents an annual dividend yield of 2.25%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.67.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,204,119 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.66 in its last earnings report, missing expectations of $0.67. Following the earnings report the stock price went down -11.914%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$103.00 (25.43% Upside)
$103.00 (25.43% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 3.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 15.8%
Last 30 Days ▼ 15.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-3.11%
12-Months-Change
Fundamentals
Return on Equity
7.30%
Trailing 12-Months
Asset Growth
16.23%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
USPH Company Deck
USPH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call revealed a strong performance with significant growth in patient visits and gross profit, alongside strategic initiatives that promise future benefits. While there were challenges such as Medicare rate reductions, the overall outlook, including new CMS rules and internal efficiency projects, is optimistic.View all USPH earnings summariesUSPH Stock 12 Month Forecast
Average Price Target
$103.00
▲(25.43% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
Pennant Group
―
Ownership Overview
1.90% Insiders
31.69% Mutual Funds
3.42% Other Institutional Investors
37.90% Public Companies and
Individual Investors